Neuren Pharmaceuticals Limited (ASX:NEU)
Australia · Delayed Price · Currency is AUD 11.93
-0.27 (-2.21%)
Apr 28, 2026, 4:10 PM AEST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of 1.54 billion as of April 28, 2026. Its market cap has increased by 28.40% in one year.
Market Cap
1.54B
Enterprise Value
1.25B
Revenue
64.65M
Ranking
n/a
PE Ratio
52.43
Stock Price
11.93
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.54B, an increase of 7,271.98%. That is a compound annual growth rate of 22.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.54B | -34.54% |
| Dec 31, 2025 | 2.36B | 48.44% |
| Dec 31, 2024 | 1.59B | -50.04% |
| Dec 29, 2023 | 3.18B | 217.33% |
| Dec 30, 2022 | 1.00B | 110.88% |
| Dec 31, 2021 | 474.89M | 222.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 5.05B |
| Mesoblast | 2.84B |
| PYC Therapeutics | 1.27B |
| Clarity Pharmaceuticals | 1.09B |
| Opthea | 738.77M |
| Racura Oncology | 517.08M |
| Clinuvel Pharmaceuticals | 455.87M |
| Starpharma Holdings | 303.23M |